Committee for Advanced Therapies (CAT): 17-19 April 2024, European Medicines Agency, Amsterdam, the Netherlands, from 17 April 2024 to 19 April 2024
Herbal medicinal product: Malvae foliumArray,Array, F: Assessment finalised
FDIME Announces the 19th FDIME-EFIM Clinical Research Course, Paris from 9 - 11 October 2024.
Human medicines European public assessment report (EPAR): Zynyz, retifanlimab, Date of authorisation: 19/04/2024, Status: Authorised
CAT quarterly highlights and approved ATMPs - February - April 2024
Quality of medicines questions and answers: Part 1
Guideline on stability testing for applications for variations to a marketing authorisation for veterinary medicinal products
Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Date of authorisation: 23/02/1998, Revision: 42, Status: Authorised
Concept paper on revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labelling
List of eligible industry stakeholder organisations